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A microfluidic flow-based platform (lFP), able to stimulate platelets via exposure
of shear stress patterns pertinent to cardiovascular devices and prostheses, was
compared to the Hemodynamic Shearing Device (HSD)—a state-of-the-art bench-
top system for exposure of platelets to defined levels and patterns of shear.
Platelets were exposed to time-varying shear stress patterns in the two systems; in
detail, platelets were recirculated in the lFP or stimulated in the HSD to replicate
comparable exposure time. Shear-mediated platelet activation was evaluated via (i)
the platelet activity state assay, allowing the measurement of platelet-mediated
thrombin generation and associated prothrombotic tendencies, (ii) scanning elec-
tron microscopy to evaluate morphological changes of sheared platelets, and (iii)
flow cytometry for the determination of platelet phosphatidylserine exposure as a
marker of shear activation. The results revealed good matching and comparability
between the two systems, with similar trends of platelet activation, formation of
microaggregates, and analogous trends of activation marker exposure for both the
HSD and microfluidic-stimulated samples. These findings support future translation
of the microfluidic platform as a Point-of-Care facsimile system for the diagnosis
of thrombotic risk in patients implanted with cardiovascular devices. Published by
AIP Publishing. https://doi.org/10.1063/1.5024500
INTRODUCTION
Flow-based platforms are rapidly emerging as next generation approaches for the evalua-
tion of the thrombotic risk in patients implanted with mechanical circulatory support devices
(MCSDs), i.e., ventricular assist devices (VADs), mechanical heart valves, and the total artifi-
cial heart, and in patients undergoing treatment with acute blood recirculating devices (e.g.,
blood oxygenators). Such flow-based diagnostic platforms offer the potential for reliable evalua-
tion of platelet responsiveness to the specific, dynamic hemodynamic environment within these
devices, in contrast to conventional static non-flow diagnostic systems.
Supra-physiologic hemodynamic shear stress has been shown to act as a mechanical agonist
of platelet activation, having major implications in the initiation and progression of the throm-
botic process (Slepian et al., 2017). In addition, recent clinical studies have firmly established
an effective correlation between shear-mediated platelet activation (SMPA) and the develop-
ment of thromboembolic complications in VAD patients (Valerio et al., 2015; Consolo et al., in
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press). Previous studies have characterized the platelet response to shear stress in VADs (Chiu
et al., 2014), mechanical heart valves (Nobili et al., 2008), the total artificial heart (Marom
et al., 2014), and blood oxygenators (Pelosi et al., 2014; Consolo et al., 2016a). Moreover, we
have recently shown that specific hemodynamic component elements of the shear stress pattern
contribute differently to overall SMPA and that a high temporal variation of the shear stress is
a major determinant of activation (Consolo et al., 2017).
Despite emerging interest in flow-based platforms, their use has remained limited to labora-
tory and basic research activities, with translation to the clinic as effective diagnostic tools for
assessing thrombogenic risk remaining to be established. The primary reason for limited transla-
tion to date stems from the fact that current bench-top flow-based systems, in the form of dif-
fering viscometer configurations (i.e., parallel-plate, Couette, or a combination of both), consist
of large complex instrumentation, requiring significant volumes of the sample for a single
in vitro test. These characteristics reduce the potential utility of these systems for use as routine
diagnostic instruments. In addition, the levels of shear stress that can be replicated in these
bulky laboratory devices remain limited by the pressure magnitude as “tens” of Pascals to avoid
secondary flows in the fluid chamber impairing uniform stimulation of the platelet sample.
Thus, shear stress conditions attainable in these systems inadequately emulate shear conditions
experienced by platelets in actual clinical cardiovascular therapeutic devices.
More recently, microfluidic flow-based platforms (lFPs) have been proposed as novel
approaches for evaluating shear-mediated platelet responses and associated thrombosis
(Gutierrez et al. 2008; Hansen et al. 2013; Hosokawa et al. 2011; Li et al. 2014; and Li and
Diamond, 2014). However, most of these systems are able to expose whole blood or platelet
samples to physiologic and time-constant shear stress conditions, such as those occurring in the
microcirculation. So far, the use of lFPs for the analysis of SMPA in response to highly
dynamic hemodynamic conditions pertinent to cardiovascular devices has not yet been
exploited.
To overcome these limitations, we developed a new computational fluid dynamic-based
approach, which allows the design of specific microfluidic channels able to stimulate platelets
with dynamic and highly controlled shear stress patterns of differing amplitudes (Dimasi et al.,
2015). Utilizing this approach, we demonstrated the feasibility of configuring lFPs to emulate
realistic MCSD shear stress conditions (Consolo et al., 2016b); furthermore, these microfluidic
platforms were successfully utilized for testing the efficacy of differing antiplatelet agents under
hyper-shear conditions (Dimasi et al., 2017). The microfluidic approach, as a result of its ability
to employ small sample volumes, its highly controllable working conditions, and the possibility
for automation, is an attractive strategy with great potential for precision medicine. Its full
translation will allow for determination of the patient-specific thrombotic risk associated with
SMPA and platelet responsiveness to antiplatelet therapy readily at the bedside.
Despite the demonstrated capability of microfluidic flow-based platforms, their efficacy
with regard to their defined ability to induce defined shear-mediated platelet activation has not
yet been validated with respect to state-of-the-art accepted flow-based systems, as the
Hemodynamic Shearing Device (HSD). The HSD is a computer-operated modified “cone and
plate” and Couette viscometer designed to expose platelets to defined levels of dynamic or con-
tinuous shear stress uniformly distributed within the flow field. This well-established bench-top
device allows the recreation of a wide range of shear stress conditions (either physiological or
abnormal) in vitro and has been successfully utilized in previous studies to guide rational
device design optimization and minimization of the thrombogenic potential of a range of car-
diovascular devices (Sheriff et al., 2014; Alemu et al., 2010; Piatti et al., 2015) and to develop
and calibrate mathematical models of SMPA (Soares et al., 2013; Sheriff et al., 2013). In the
present study, we hypothesized that the performance of lFPs, with regard to specific, defined
shear-mediated platelet activation, will closely parallel and emulate that of the HSD, over a
range of shear test conditions. As such, herein, we compared shear-mediated platelet activation,
platelet shape change, and procoagulant activity, induced by exposure to dynamic shear stress
conditions emulated in vitro in the lFP versus the HSD.
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MATERIALS AND METHODS
Platelet sample preparation
30 ml of whole blood was drawn via venipuncture from healthy adult volunteers following
informed consent, collected into 10% anticoagulant acid-citrate-dextrose solution, and centri-
fuged at 450g for 15min to obtain platelet rich plasma. Platelet rich plasma was filtered through
a Sepharose 2B column (Sigma-Aldrich, St. Louis, MO, USA) to obtain isolated gel-filtered
platelets (GFPs). GFPs were counted using a Z1 Particle Counter (Coulter, Miami, FL, USA)
and diluted to the desired final concentration (according to the specific test to be performed) in
a platelet buffer consisting of Ca2þ-free HEPES-modified Tyrode’s buffer containing 0.1%
fatty-acid-free bovine serum albumin. GFPs were re-calcified with CaCl2 (3mM final concen-
tration) 10min prior to testing and were then exposed to dynamic shear stress patterns in lFPs
or the HSD or as described below. All experiments were conducted within 6 h of phlebotomy.
Shear-mediated platelet activation in the hemodynamic shearing device
The HSD apparatus has been described in detail previously (Girdhar and Bluestein, 2008).
Briefly, it consists of a programmable high-torque servo-motor controller system that drives a
cone in a combined cone and plate-Couette system. The HSD fluid chamber configuration
allows exposure of the sample to uniform shear stress. The device can be programmed to gener-
ate highly dynamic patterns of shear stress in a step-like manner (with a resolution up to 3ms).
To induce SMPA in the HSD, human GFPs were subjected to devised dynamic shear stress
conditions replicating specific features characteristics of MCSDs. In detail, simulated shear
stress patterns are characterized by repetitive peaks of shear stress with a fixed peak value
(5 Pa) and differing peak durations and time intervals between consecutive peaks. These time-
varying dynamic shear patterns, termed as Dyn1 and Dyn2, were selected to be properly repli-
cated by the HSD, i.e., avoiding secondary flows in the fluid chamber impairing uniform stimu-
lation of the platelet sample. The dynamic shear stress curve is shown in Fig. 1; Dyn1 and
Dyn2 shear stress pattern characteristics are specified in Table I.
Dyn1 and Dyn2 were programmed in the HSD. For each curve, 3.5ml of re-calcified GFPs
(100 000 cells/ll) was placed in the HSD fluid chamber. The system was first run for 10 s at
0.1 Pa to allow leveling out the GFPs in the shearing chamber, at which point the specific
shearing program (either Dyn1 or Dyn2) was initiated. For the time point sample collections
(TP, TPs 1–4), the system was programmed to slow down to 0.1 Pa for 30 s to allow collection
of 200 ll of sheared GFPs, performed by manually withdrawing the sample with a 1ml plastic
tuberculin syringe connected to a lateral access port of the fluid chamber via polyethylene tub-
ing (1.0mm internal diameter and 5 cm length). Upon collection, samples were immediately
processed for platelet activation analyses as described below. For each blood donor, consecutive
tests were conducted for Dyn1 and Dyn2 shear conditions. Between consecutive tests, the HSD
chamber and the collection system were extensively flushed with HEPES-modified buffer, while
FIG. 1. Curve of the dynamic shear stress pattern utilized in the study. Repetitive triangular-shaped peaks characterized by
a fixed peak of shear stress (5 Pa) but with differing peak duration (Tp) and time between consecutive peaks (Tlag).
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between different donors, the system was flushed with 0.5% Sodium dodecyl sulphate in
50mM NaOH, followed by extensive flushing with the HSD platelet-contacting surfaces using
Sigmacote
VR
(Sigma Aldrich, USA), followed by air drying.
Microfluidic channel design and platform fabrication
The microfluidic platform was designed according to the approach described by our group previ-
ously (Dimasi et al., 2015). Briefly, the geometry of each model is designed according to preliminary
analytical formulae and then optimized through the Computational Fluid Dynamics analyses; multi-
phase computational fluid dynamic analyses are run in which the fluid dynamic in the microfluidic
channel is simulated while calculating the trajectories of thousands of virtually injected platelets.
The dynamic shear stress curves along platelet trajectories in the microchannel are then
exported and analyzed. From all the shear stress curves, a representative curve is extracted: for
this aim, shear stress curves are summarized in a scalar index, i.e., the stress accumulation, cal-
culated as the linear integral of the shear stress over time, and the curve closest to the median
of the distribution of the stress accumulation value is selected as the representative shear stress
curve of the channel.
Finally, a semi-automatic iterative algorithm allows us to optimize channel geometrical
parameters (widths and lengths of the shear stress-generating features) based on the discrepancy
between descriptive parameters of the shear stress waveforms along platelet trajectories in the
microfluidic channels and the reference shear stress waveform to be replicated.
To replicate Dyn1 and Dyn2, two specific channel geometrical configurations were identi-
fied as shown in Fig. 2. Microchannel dimensions were chosen as a compromise between stan-
dard photo-lithography manufacturing capabilities, while guaranteeing the validity of continuum
flow hypothesis used in the designing process (Dimasi et al., 2015), and the need for limiting
TABLE I. Characteristics of dynamic shear stress pattern conditions. The baseline (sbase), peak shear stress (speak), peak
duration (Tp), time between consecutive peaks (Tlag), and shear exposure time (time points, TP 1–4) are reported.
Shear stress curve characteristics Time points (TPs)
sbase (Pa) speak (Pa) Tp (ms) Tlag (ms) TP 1 TP 2 TP 3 TP 4
Dyn1 1 5 40 90 10 30 60 90
Dyn2 1 5 160 360 10 30 60 90
FIG. 2. A microfluidic platform for dynamic shear stress conditions. Top panel: 3D Computer Aided Design (CAD) model
of a lFP sample, with a zoomed view on the channel features. Bottom panel: schematic drawing of the lFP channel design
where geometrical parameters are reported.
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the flow rates and hence the pressures in the microchip. The channels are characterized by
subsequent cross-section narrowings, whose dimensions are reported in Table II: Wfeat and
Lfeat and Llag refer to the width and length of the narrowing feature and the length of the
straight portion of the channel between consecutive features, respectively. Nfeat indicates the
number of feature repetitions on a single channel. The latter was set to guarantee estimated
pressure drops across the platforms below 2 atm to avoid fluid leakage during the test
performance.
Micropatterned silicon wafers were fabricated via standard photolithography using a nega-
tive photoresist SU-8 2050 (Microchem Corp, USA) in a cleanroom facility. Fabrication of the
microfluidic platforms was then obtained by replica molding of polydimethylsiloxane and sub-
sequent sealing on 35mm 50mm cover glasses through plasma bonding. A 3D CAD model
of a representative lFP is shown in Fig. 2.
Microfluidic platform testing
Recirculation of the GFP sample in the lFP was implemented to allow exposure time to
shear longer than TP 1 and to match time points of platelet analysis as used in HSD experi-
ments. For this aim, two synchronized syringe pumps operating in the reciprocating mode
were employed, via which GFPs were alternatively pumped back and forth through the lFP
in a closed hydraulic system. In detail, two syringe pumps (AL2000, World Precision
Instrument, UK) equipped with 250 ll precision glass syringes (Hamilton Gastight 1725 TLL
syringes) were connected to 508 lm internal diameter TygonVR tubes 25 cm long through 23G
disposable blunt needles. Tubes were then connected to the access ports of the lFP through
two stainless steel couplers (23G, 1 cm long). The setup for lFP recirculation experiments is
shown in Fig. 3.
After passivating the lFP tubing with 3% w/v bovine serum albumin in phosphate buffered
saline (PBS) for 1 h at room temperature, and subsequently washing with PBS, each tube was
filled with 45 ll of re-calcified GFP sample (100 000 cell/ll) by withdrawal from a 0.65ml
TABLE II. Geometrical characteristics of the two different microfluidic channels replicating Dyn1 and Dyn2 shear stress
curves and the corresponding flow rates. The channel height (h), width (W), and length (L) are reported together with the
parameters referring to geometrical characteristics of the channel features generating the shear stress peaks: the width and
length of the feature (Wfeat and Lfeat), the length of the straight portion of the channel between consecutive features (Llag),
and the total number of features on the same channel (Nfeat). In both cases, a flow rate value Q equal to 15ll/min was used.
h (lm) W (lm) Wfeat (lm) Lfeat (mm) Llag (mm) Nfeat Q (ll/min)
Dyn1 50 200 44 2 1.75 288 15
Dyn2 50 200 44 8 7.00 72 15
FIG. 3. Setup of synchronized syringe pumps for reciprocating pumping of GFPs in the lFP (left panel). The picture of the
microfluidic platform during the sample collection that followed GFP recirculation (right panel).
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Eppendorf tube at the predefined flow rate (see Table II) via the syringe pumps. One tube was
connected to the lFP, and filling was started by pumping the GFP sample at the same flow
rate. A sample of 15 ll at the outlet of the lFP was first discarded, and the remaining 30 ll was
collected as the TP 1 sample for Platelet Activation State (PAS) assay and scanning electron
microscopy (SEM) analysis (as described in the next two sections). The second tube was then
connected to the free port of the platform to close the system, and the reciprocating pumping
was started: 40 ll of GFP in the second tube was alternatively pumped back and forth through
the lFP until the desired shearing time (TPs 2, 3, or 4) was achieved. At this point, the system
was opened, and 30 lL of sheared sample was collected in a 0.65ml Eppendorf tube (Fig. 3,
right panel) and tested.
For the PAS assay, 3 consecutive tests were performed on the same platform to obtain TP
1 and TP 2 in the first run and TP 3 and TP 4 in two further runs. Between consecutive runs,
the system was extensively flushed with PBS. Two different platforms replicating Dyn1 and
Dyn2, respectively, were tested with the same blood donor.
Scanning electron microscopy
Scanning electron microscopy (SEM) was performed to visualize early platelet morphologi-
cal changes, occurring as a result of dynamic shear exposure to Dyn1 and Dyn2 in HSD and
lFPs. The serial SEM images were acquired on samples exposed to shear at 2 different time
points (TP 1 and TP 4 as defined in Table I). Following shear exposure, 30 ll aliquots of GFP
(100 000 cells/ll) was deposited on glass coverslips (13mm diameter). Samples were immedi-
ately fixed by adding 30 ll of 2% v/v glutaraldehyde in HEPES-modified platelet buffer. After
30min incubation at room temperature, coverslips were washed through successive dilutions of
glutaraldehyde in ddH2O. Finally, successive dilutions of ddH2O in ethanol (up to 100% etha-
nol) were used to dehydrate the samples. Coverslips were mounted on metal stubs using
double-sided adhesive carbon tape. After gold-coating treatment performed using an Anatech
Hummer 6.6 (Anatech, USA) sputter system, SEM image acquisitions were performed on an
FEI Inspec-S SEM (FEI Company, USA). As an unstimulated control, intact GFP samples were
also imaged. SEM imaging was performed on 2 different donors.
Platelet activity state assay
To characterize the dynamics of SMPA over the shear exposure time, a chromogenic plate-
let activity state (PAS) assay measuring thrombin generation on the surface of shear-stimulated
platelets was utilized (Jesty and Bluestein, 1999). Specifically, GFP samples collected from the
lFP and the HSD at differing time points (TP 1–4) were assessed. 25 ll aliquot of sheared GFP
(20 000 cells/ll) was incubated for 10min at 37 C in the presence of acetylated prothrombin,
CaCl2, and factor Xa. During the incubation, acetylated prothrombin is activated into acetylated
thrombin by factor Xa, and the enzymatic reaction rate directly depends on the prothrombotic
activity of platelets (i.e., their activation level induced by shear exposure). Unlike the native
enzyme, acetylated thrombin possesses amidolytic activity on the peptide substrate and is inca-
pable of activating platelets in a positive feedback manner, allowing stoichiometric correlation
of thrombin generation rate to the actual level of SMPA (Jesty and Bluestein, 1999). To quan-
tify thrombin generation, a VersaMaxTM ELISA Microplate Reader (Molecular Devices LLC,
CA, USA) was used. Kinetic measurements of absorbance changes were conducted in the pres-
ence of a chromogenic substrate for thrombin, Chromozym TH (Roche, Switzerland). The rate
of absorbance change obtained for each sheared GFP sample was normalized against the corre-
sponding values of sonicated GFP. As sonication induces maximum prothrombinase activity,
PAS values are reported as a percentage of sonicated SMPA, with 100% activation established
from measured sonicated samples. GFPs were sonicated at 75W (40 kHz) for 10 s using an
ultrasonic device (SLPE Branson, USA). PAS experiments were conducted on 6 different
donors.
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Flow cytometry detection of platelet phosphatidylserine exposure
To detect phosphatidylserine exposure induced by shear stress, an annexin V binding assay
was performed. The principle of the assay is based on the high affinity binding of the protein
annexin V labeled with fluorescent dye to phospholipid phosphatidylserine exposed on the platelet
surface as a result of activation or apoptosis. For flow cytometry analyses, GFPs were used at a
concentration of 100 000 cells/ll. Following shear exposure (at TP 4), 30ll of collected GFP was
incubated with 5ll Fluorescein Isothiocyanate (FITC)-conjugated annexin V (Molecular Probes,
USA) in 70ll of binding buffer consisting of 10mM HEPES, 140mM NaCl, and 2.5mM CaCl2
at pH 7.4. After 30min incubation at room temperature in the dark, samples were fixed by adding
300ll of 4% v/v paraformaldehyde in PBS. After 20min, samples were centrifuged at 5000 rpm
for 5min, the supernatant was removed, and the platelet pellet was re-suspended in 500ll of
50mM phosphate buffer free of Ca2þ and Mg2þ. This step was performed twice, and the sample
was transferred in 12 75mm polystyrene Falcon tubes. Flow cytometric analysis was performed
on a FACScan flow cytometer (BD Biosciences, San Jose, CA, USA) equipped with an air-
cooled 15mW argon ion laser tuned to 488 nm. The emission fluorescence of FITC-conjugated
Annexin V was detected and recorded through a 530/30 bandpass filter in the FL1 channel. List
mode data files consisting of 10 000 events gated on forward scatter (FSC) vs side scatter (SSC)
were acquired. Raw data exported as fcs files were subsequently analyzed using Matlab
VR
2015b
(Mathworks, USA). Appropriate electronic compensation was adjusted by acquiring unstimulated
GFPs stained with the fluorophore and unstained GFPs as a control for autofluorescence. A posi-
tive control was also tested consisting of GFPs stimulated in the HSD system at a constant shear
stress of 7 Pa for 10min. Flow cytometry analyses were performed on two different donors.
Statistical analyses
Statistical analyses of assay results were performed with GraphPad Prism 7.2 (GraphPad
Software, Inc., CA, USA). Normal distribution of data was first tested with the Shapiro-Wilk nor-
mality test. One-way Analysis of Variance (ANOVA) was used when normality hypothesis was sat-
isfied for all the groups being tested. Alternatively, non-parametric Kruskal–Wallis one-way
ANOVA was performed. For multiple comparisons, the Bonferroni post-hoc test was used to test
significant differences between groups. The statistical significance was assumed for p-values< 0.05.
RESULTS AND DISCUSSION
The current study focused on the comparability of platelet activation induced via shear expo-
sure within microfluidic flow-based platforms (lFPs), which generate shear stress via traverse
through defined complex geometry channels, as compared with activation induced via shear expo-
sure in the established standard, programmable HSD modified cone and Couette system. Two
simulated dynamic shear stress patterns (Dyn1 and Dyn2) characterized by repetitive peaks of
shear stress with a fixed peak value (5Pa) and differing peak durations and time intervals
between consecutive peaks were employed. These time-varying dynamic shear patterns were
selected to be properly replicated by the HSD, i.e., avoiding secondary flows in the fluid chamber
impairing uniform stimulation of the platelet sample. To evaluate platelet activation and function
alterations, the followings were done: (i) changes in the platelet morphology, as an early marker
of SMPA, were examined via SEM; (ii) platelet procoagulant activity driven by shear exposure
was determined as the rate of thrombin generation measured via the PAS assay; and (iii) flow
cytometry detection of annexin V binding was conducted to reveal phosphatidylserine exposure
as a result of platelet membrane reorganization in response to shear stress.
Platelet morphology alterations induced by dynamic shear stress
Platelet samples exposed to Dyn1 and Dyn2 shear patterns via the lFP or the HSD were
acquired at TP 1 and TP 4, corresponding to 1 and 8min of shear exposure time, respectively.
At TP 1 of shear exposure, morphological characteristics of SMPA were observed in both lFP-
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and HSD-sheared platelet samples (Fig. 4, “Dyn1—1min”). Specifically, platelet contraction
and filopodia extrusion were prominently observed in the shear-stimulated platelets, as com-
pared to the preservation of a discoid morphology and homogeneous membrane configuration
in non-stimulated platelet controls (Fig. 4, “Resting GFP”). No relevant differences between
lFP- and HSD-shear stimulated samples in terms of platelet morphology alterations were found.
This agreement obtained between microfluidic platforms and the HSD provides supportive evi-
dence that controlled shear stress conditions can be effectively generated in the lFP by properly
modulating the channel geometry design. Interestingly, after longer exposure time to shear (TP
4) in the lFP and the HSD, microaggregates of platelets were observed following stimulation
with either Dyn1 or Dyn2 shear patterns.
Platelet procoagulant activity driven by dynamic shear exposure in lFP and HSD
The extent of platelet activation followed by exposure to dynamic shear stress was evalu-
ated using the PAS assay, as a functional approach measuring the rate of thrombin activation
by factor Xa on the platelet surface after stimulation. In Fig. 5, the results of the PAS assay
FIG. 4. Morphologic changes of human platelets subjected to dynamic shear stress patterns Dyn1 and Dyn2 in the micro-
fluidic platforms (“Microfluidics”) and the hemodynamic shearing device (“HSD”) as compared with intact platelets
(“Resting GFP”). SEM images were acquired at TP 1 (1min) and TP 4 (8min) of shear exposure.
FIG. 5. Platelet procoagulant activity induced by exposure to dynamic shear stress patterns Dyn1 and Dyn2 in the micro-
fluidic platforms (“Microfluidic”) and the hemodynamic shearing device (“HSD”). The results are reported as mean6 stan-
dard deviation.
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performed on GFP sheared via the lFP and the HSD are reported for Dyn1 and Dyn2 at differ-
ing time points (from 0 to 9min). For both dynamic shear patterns, a time-dependent increase
in SMPA was observed. For longer exposure times (TP 3 to TP 4), a smaller increase in SMPA
was noted. This is in agreement with previous studies on SMPA in which similar trends and
PAS levels were obtained by exposing platelets in the HSD to dynamic shear stress conditions
comparable to those considered in the present study (Sheriff et al., 2013).
In Fig. 6, the PAS difference between TP 4 and non-stimulated control is reported accord-
ing to Sheriff et al., 2013. Comparable PAS values were obtained in the lFP and the HSD for
both Dyn1 and Dyn2 shear patterns (Dyn1: p¼ 0.96; Dyn2: p¼ 0.31). Although not statistically
significant, the Dyn2 condition was associated with a lower increase in platelet activation with
respect to control, both in the HSD and lFP. This result is again in agreement with a previous
study in which lower activation was observed from dynamic and periodic shear stress patterns
characterized by longer time periods of the dynamic waveform (Sheriff et al., 2013). Indeed,
Dyn2 is characterized by a time period of 520ms, compared to 130ms of Dyn1.
In Fig. 7, the correlation curve between PAS data obtained in the HSD and in the lFP is
shown for both Dyn1 and Dyn2 (left panel). The Bland-Altman plot obtained from the same
data is reported in Fig 7 (right panel). A good correlation between microfluidic- and HSD-
stimulated platelets was observed (R2¼ 0.62). From the Bland-Altman plot, no systematic or
proportional difference phenomenon was found, suggesting that similar levels and trends of
platelet activation can be achieved by properly designing the lFP channel geometry.
FIG. 6. The increase in platelet activity state levels after exposure to dynamic shear stress patterns Dyn1 and Dyn2 (DPAS,
TP 4 and TP 0) via the microfluidic platform (“Microfluidic”) and the hemodynamic shearing device (“HSD”). The results
are reported as mean6 standard deviation (n¼ 6).
FIG. 7. Correlation between PAS results obtained in the microfluidic platforms and in the HSD (left panel) and Bland-
Altman plot (right panel).
042208-9 Dimasi et al. Biomicrofluidics 12, 042208 (2018)
Platelet phosphatidylserine exposure resulting from exposure to dynamic shear
Flow cytometry was performed to examine platelet membrane eversion and aminophospho-
lipid exposure following dynamic shear stimulation in the lFP as compared with the HSD.
Platelets presenting phosphatidylserine on their surface were identified via an annexin V bind-
ing assay. Different platelet populations were distinguished based on two output fluorescence
parameters: the fluorescence pulse area (FITC-A) and the fluorescence pulse width (FITC-W).
The gate setup and annexin V-positive platelet population distribution are reported in Fig. 8;
intact platelets and high-shear stimulated platelets are shown as negative and positive controls,
respectively. The unstained control [Fig. 8(a)] was employed to define the gate for platelet auto-
fluorescence (P1 region) and to identify platelets not binding annexin V on their surface.
Consequently, gates P2 and P3 represent two platelet populations (outside of the P1 region)
binding different levels of annexin V: the P3 region—clearly distinguishable in the positive
control—identifies the population of platelets characterized by a very high fluorescence pulse
area, while region P2 identifies platelet population with lower annexin V binding and was
defined as the intermediate region between P1 and P3.
Representative populations at the FITC-A vs FITC-W plane for the Dyn1 and Dyn2 sam-
ples at TP 4 are reported in Fig. 9 for both the HSD- and lFP-stimulated platelets. Overall, all
sheared samples showed a greater density P2 region as compared to the negative stained control
[Fig. 8(b), “Resting platelets”], indicating an increase in platelet phosphatidylserine exposure
after shear stimulation. A slight increase in platelet density in the P3 region, as compared to
negative stained control, was indeed observed in HSD-stimulated samples (both Dyn1 and
Dyn2) but not evident in lFP-stimulated samples.
The heterogeneity of identified platelet populations (P1, P2, and P3) for Dyn1 and Dyn2
samples is shown at histogram of FITC-A distribution (Fig. 10). Slightly higher qualitative
prevalence of platelets in the P2 and P3 regions was observed in HSD-stimulated samples. A
quantitative comparison is provided in Table III, where the values of population prevalence
(expressed as percentage over the total events acquired) and the mean values of FITC-A in P1,
P2, and P3 are reported. Also, the same values obtained for the negative stained control are
shown (resting platelets).
A decrease in the platelet number in the P1 region was found for all sheared samples with
respect to controls, with a corresponding increase in the platelet number in the P2 region, indic-
ative of increased platelet binding of annexin V. The last observation is aligned with PAS
results, showing an increase in thrombin generation of sheared samples with respect to non-
stimulated platelets (Fig. 5). Indeed, aminophospholipid exposure on the platelet outer mem-
brane provides a surface for the assembly of the prothrombinase complex, which in turn leads
to thrombin formation. Overall, a low prevalence of platelets in the P3 region was found for all
conditions tested. In the Dyn1 condition, a larger difference was obtained between HSD- and
FIG. 8. Fluorescence pulse area (FITC-A) versus width (FITC-W) in control platelet samples: (a) unstained non-stimulated
platelets (autofluorescence control), (b) non-stimulated platelets (negative control), and (c) platelets exposed to 7 Pa contin-
uous shear stress in the HSD for 10min (positive control).
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FIG. 9. Phosphatidylserine exposure on platelet surfaces following stimulation (TP 4) with dynamic shear patterns Dyn1
(a) and Dyn2 (b) applied in the HSD (top) and microfluidic platforms (bottom).
FIG. 10. Histogram distributions of FITC-A of the three separate populations (P1 grey, P2 green, and P3 red) for Dyn1 (a)
and Dyn2 (b) shear stress conditions at TP 4 from the HSD (top) and the microfluidic platforms (bottom). The values of
FITC-A in the P3 population were reported only when a prevalence greater than 1% was found.
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lFP-sheared samples. A better matching was found between HSD and microfluidics for the
Dyn2 condition.
Interestingly, in terms of uniformity of FITC-A distribution, no relevant differences were
obtained in the microfluidic and HSD systems. This result is of particular interest in the present
study as it shows that despite the fact that the microfluidic shearing platform is intrinsically
characterized by a larger variability of shear stress conditions (due to fluid paths characterized
by different shear stresses and exposure times in the same channel), this intrinsic variability is
not reflected in a larger heterogeneity of pro-coagulant marker expression among the population
of platelets when compared to the HSD. The latter indeed is purposely designed to generate a
uniform shear stress field in the sample chamber.
Flow cytometry analyses thus provided a further insight into the evaluation of the microfluidic
shearing system, showing that similar distributions of platelet response in terms of peak stress expo-
sure following controlled shear stress conditions in microfluidic and HSD systems could be obtained.
CONCLUSION
In the present study, we assessed microfluidic flow-based platforms, designed via a compu-
tational fluid dynamic-based approach to emulate shear stress patterns and components of
mechanical circulatory support devices, as to their efficacy of inducing shear-mediated platelet
activation in comparison to that achieved with the accepted and established laboratory-standard
approach of the hemodynamic shearing device system. Specifically, the dynamics of platelet
activation over a range of differing shear exposure times was evaluated via (a) the PAS
assay—a chromogenic assay of platelet thrombin generation, (b) SEM imaging of morphologic
alterations of sheared platelets, and (c) flow cytometry analysis—to evaluate platelet exposure
of activation markers (Annexin V). In this study, we found that comparable trends of PAS val-
ues were obtained with the microfluidic platform in comparison to the HSD. Furthermore, we
demonstrated that microfluidic flow-based platforms induced comparable formation of platelet
microaggregates, as compared with those formed with the HSD, particularly for longer shear
exposure times. These SEM results morphologically confirm the functional activation data dem-
onstrated via the PAS assay result. Flow cytometry similarly revealed an analogous trend of
exposure of activation markers with microfluidic flow-based platforms as was generated with
identical shear exposure in the HSD. All in all, these results provide functional biochemical
(PAS assay), morphologic (SEM), and marker (Annexin V) data, confirming the similarity and
efficacy of microfluidic flow-based platforms (lFP) as effective, reliable, practical small foot-
print surrogates of defined shear pattern platelet activation in comparison to the HSD.
Value and advantages of microfluidic flow-based platforms (lFPs)
Microfluidic flow-based platforms (lFPs) extend the armamentarium of methodologies
available for fluid and mechanobiologic studies of platelet activation from several perspectives.
Microfluidic platforms require minimal volumes of blood for analysis. Typically, 1–2ml of
TABLE III. Platelet population heterogeneity (P1, P2, and P3) for the shear stress conditions tested (Dyn1 and Dyn2) in
the HSD system and the microfluidic platforms.
Population prevalence (%) Mean FITC-A (AU)
P1 P2 P3 P1 P2 P3
Resting platelets 80 19 1 145 700 …
Micro–Dyn1 66 33 1 161 900 …
HSD–Dyn1 54 44 2 176 1000 52 000
Micro–Dyn2 57 42 2 185 1000 67 000
HSD–Dyn2 54 44 2 186 1000 67 000
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blood is all that is needed to generate the few microliters of platelets—presently with conven-
tional upstream processing to separate platelets from whole blood—then load, and run platelets
through the (lFP) shear channels. In the future, with incorporation of an integrated upstream
platelet separation capability, blood requirements may conceivably be further reduced to a mini-
mal requirement of a finger prick—i.e., with<100 microliters, for such a system. Present lFPs,
as well as envisioned integrated system lFPs, would extend utility and analysis to small animal
research in which overall blood volumes are minimal and obtaining samples is more difficult.
Microfluidic flow-based platforms (lFPs) also offer the advantage of reduced consumption of
reagents. Buffers and antibodies, affording an overall reduction in the cost of analysis.
Microfluidics offers the potential for automated processing, which could be readily inte-
grated with a lFP system for pre-processing and post-processing steps—i.e., for isolation of
platelets from whole blood and for assay incorporation (PAS), allowing quantization of platelet
activation. In the literature, indeed, several examples of microfluidic approaches have been
described to separate blood components (e.g., hydrophoresis: Hou et al., 2015) and to measure
platelet activation (e.g., aggregometry: Schimmer et al., 2013), which support our concept of an
eventual integrated system being developed based on the herein described lFPs.
From a flow perspective, microfluidic flow-based platforms (lFP) allow attainment of very
high shear stress levels under laminar flow regimes, thus replicating hyper-shear values and
dynamics occurring in prosthetic cardiac devices. Additionally, their characteristic high surface-
to-volume ratio implies extremely controlled and precise handling of fluids and compounds,
i.e., for highly repeatable processes. In comparison, the HSD is a bulky system, requiring large
volumes of blood and significant reagent volumes, and has been limited in its use as to the
level of shear stress generated. Furthermore, the large volume requirement has made small ani-
mal investigation difficult if not prohibitive, e.g., for mice, and is not amenable to clinical
translation as either a laboratory or point-of-care instrument.
Study limitations
The two dynamic shear stress conditions tested (Dyn 1 and Dyn 2) were selected in order
to guarantee effective uniform stimulation of platelets within the HSD. As they were found to
result in similar levels of platelet activation, this observation may raise some concerns, as we
were not able to evaluate the sensitivity of the microfluidic flow-based platform compared to
the HSD. From this perspective, future studies should be further expanded to the analysis of
shear stress conditions with differing characteristics in terms of shear stress patterns inducing
eventually differing platelet activation levels.
Future implications and translation
Nonetheless, this is the first study in which a microfluidic flow-based platform was employed
to replicate dynamic shear stress conditions, whose hemodynamic characteristics were selected to
simulate device-like hemodynamic conditions and associated shear stress (the repetitive exposure
to the peak of shear stress resembles cyclic platelet recirculation through the device). As such,
this study is a positive step for the future translation and development of a Point-of-Care micro-
fluidic platform for bed-side assessment of patient-specific prothrombotic risk.
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